BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17097962)

  • 1. Post-kidney transplant surgical complications under new immunosuppressive regimens.
    Burgos FJ; Pascual J; Quicios C; Marcen R; Fernández A; López Fando L; Ortuño J
    Transplant Proc; 2006 Oct; 38(8):2445-7. PubMed ID: 17097962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation.
    Goel M; Flechner SM; Zhou L; Mastroianni B; Savas K; Derweesh I; Patel P; Modlin C; Goldfarb D; Novick AC
    J Urol; 2004 May; 171(5):1788-92. PubMed ID: 15076277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years.
    Marcén R; Morales JM; del Castillo D; Campistol JM; Serón D; Valdés F; Anaya F; Andrés A; Arias M; Bustamante J; Capdevila L; Escuin F; Gil-Vernet S; Gonzalez-Molina M; Lampreave I; Oppenheimer F; Pallardó L;
    Transplant Proc; 2006 Dec; 38(10):3530-2. PubMed ID: 17175323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
    Romagnoli J; Citterio F; Nanni G; Favi E; Tondolo V; Spagnoletti G; Salerno MP; Castagneto M
    Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.
    Porrini E; Delgado P; Alvarez A; Cobo M; Pérez L; González-Posada JM; Hortal L; Gallego R; García JJ; Checa M; Morales A; Salido E; Hernández D; Torres A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1436-41. PubMed ID: 18029372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy.
    Yakupoglu YK; Buell JF; Woodle S; Kahan BD
    Transplant Proc; 2006 Mar; 38(2):358-61. PubMed ID: 16549120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Individual immunosuppressive regime in heart transplantation with high risk].
    Wu XJ; Chen LW; Chen DZ; Huang XS; Cao H
    Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(11):820-2. PubMed ID: 19035214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
    Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
    Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New immunosuppressive therapies and surgical complications after renal transplantation.
    Barba J; Rosell D; Rincon A; Robles JE; Zudaire J; Berian JM; Pascual I; Errasti P
    Transplant Proc; 2012 Jun; 44(5):1275-80. PubMed ID: 22664000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in the frequency and type of infections in heart transplantation according to the immunosuppression regimen.
    Agüero J; Almenar L; Martinez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Izquierdo M; Salvador A
    Transplant Proc; 2006 Oct; 38(8):2558-9. PubMed ID: 17098001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.